IDWeek 2024: Novel antimicrobials poised to make a difference
During IDWeek 2024 in Los Angeles, California, novel antimicrobials in the development pipeline that are poised to make a difference …
During IDWeek 2024 in Los Angeles, California, novel antimicrobials in the development pipeline that are poised to make a difference …
The surge of popularity of weight loss drugs has created a rivalry with traditional device orientated approaches, but a new …
Gilead Sciences and MSD are advancing their once-weekly HIV treatment regimen to Phase II trials, following promising results from a …
Swiss skincare company Galderma has reported positive data from a Phase III clinical trial of RelabotulinumtoxinA (Relfydess) for treating moderate-to-severe …
In the backdrop of geopolitical disruptions impacting supply chains in many industries, the healthcare and pharma sectors are facing several …
Novo Nordisk plans to file a label expansion for Rybelsus (oral semaglutide) as an adjunct treatment for the prevention of …
US-based biopharmaceutical company Madrigal Pharmaceuticals has finished enrolling patients in a trial of Rezdiffra (resmetirom), a drug candidate for compensated …
Canadian biotechnology company Zymeworks has dosed the first subject in a Phase I trial of ZW171 to treat advanced or …
At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II, randomised, observer-blind, placebo-controlled, dose-ranging trial (NCT05992935) for mRNA-1403, …
Endospan has completed enrollment in the primary arm of a clinical trial evaluating its stent graft for the treatment of …
Canadian biopharmaceutical company Find Therapeutics has dosed the first subject in a Phase I trial of its lead compound, FTX-101, …
Sepsis is a life-threatening complication arising from an infection, which occurs when the body’s response to the infection damages its …
The US Food and Drug Administration (FDA) has placed a partial clinical hold on the registrational Phase III PRESERVE-003 trial …
Health and technology consulting company Nordic and BeeKeeperAI have teamed up to help expedite the use of clinical decision support …
Swiss pharmaceutical company Roche has released positive topline one-year findings from a Phase IV trial of Vabysmo (faricimab) to treat …